XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Accounting Policies [Abstract]          
Research and Development Expense $ 87,687 $ 16,669 $ 193,621 $ 157,876  
Deferred Revenue 140,000   $ 140,000   $ 140,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount     804,143,176 730,366,968  
Depreciation $ 5,465 $ 5,465 $ 16,395 $ 16,395